In our research program to investigate novel agents for anti-malodor activity from natural plant resources, we focused on Pterocarpus marsupium, which has been used as a "toothbrush tree" in Asian countries for many years. A 50% ethanol extract (PM-ext) was prepared and tested for anti-methioninase and anticollagenase activity along with suppressive activity against matrix metalloprotease (MMP)-1 from interleukin-1β stimulated human gingival fibroblast. PM-ext showed moderate anti-methioninase and anti-collagenase activity as 35 and 33% at 500 μg/mL, while PM-ext showed suppression of MMP-1 release at 10 μg/mL. The active principles of MMP-1 release suppression were revealed as pterostilbene, (+)-liquiritigenin, isoliquiritigenin and α-epi-coatline A. Among them, pterostilbene showed suppression at 0.5 μM, which was the most potent of the four compounds.
Oral malodor is a symptom that occurs in people with mental disorders and relate diseases. The pathogenesis of malodor is attributed to various factors and the pharmaco-therapeutic approach has been unsuccessful. In these circumstances, Indian traditional medicine, Ayurveda, describes the effect of tooth brushing using toothbrush trees for prevention of malodor. Toothbrush trees have been used for a long period of time. Two Ayurvedic books, Charaka Samhita and Sushruta Samhita, which were written between 300~500 A.D., describe brushing using the toothbrush tree as effective for maintaining the hygiene environment of the mouth. Among the various toothbrush trees, the twig of Pterocarpus marsupium (Asana) was reported as an effective agent for toothache and gum constriction, which is described in Charaka Samhita. According to the description, the tip of a twig should be crushed by chewing and then used to brush with care twice a day to avoid damage to the gum. The twig tastes astringent, hot and bitter and the brushing removes malodor, dirt on the tongue, teeth and mouth, enhances appetite and aids recovery from dysgeusia. From these descriptions, Asana should have an effect on the improvement of malodor to some extent.
Considering the points described above, we focused on the heartwood of P. marsupium as a promising agent for malodor treatment. In order to investigate its potential for malodor suppression, we introduced three assay systems. Firstly, inhibition of L-methionine-γ-lyase (METase). This enzyme catalyzes the conversion of methionine into methylmercaptan, which is a thiol compound responsible for malodor. METase is a bacterial enzyme released from Porphyromonas gingivalis, typical bacteria related to periodontal disease. Thus, inhibition of this enzyme directly suppresses malodor. Secondly, we used inhibition of collagenase. Collagenase destroys the gums, which consist of collagen, and this results in the deterioration of the oral condition; oral conditions are closely related to the microbes present. Gum degradation may give an advantage to periodontal disease bacteria. Thirdly, we tried suppression of matrix metalloprotease-1 (MMP-1) release from human gingival fibroblasts (HGFs). MMPs are a part of the protease family, and they catalyze the destructive process of the cells or tissues related to inflammation, tumor invasion and periodontitis [1] . Among the known MMPs, MMP-1, which known as a collagenase, is recognized as the dominant factor for gum degradation. A suppressant of MMP-1 release from HGFs may be an ideal agent for the treatment of periodontal disease and further malodor. These screening assays were recognized as effective for screening natural raw materials in a previous report [2] . In this report, we evaluated inhibitory activities against METase and collagenase along with the suppression of the release of MMP-1 from HGFs in order to evaluate the efficacy against malodor. The data from three experiments and determination of the active principles are discussed.
PM-ext showed 17 and 35% inhibition at 200 and 500 μg/mL, respectively (Table 1) . METase is a homotetrameric, multifunctional enzyme belonging to the γ family of pyridoxal-5-phosphate dependent enzymes [3] . It catalyzes α and γ removal with αγ replacement of L-methionine with the equimolar yield of α-keto acids (2-oxobutyrate and pyruvate), methane thiol and ammonia. This enzyme is known to possess anti-tumor activity. Strong inhibition of this endogenous enzyme leads to some side effects. However, the potency of PM-ext is mild and should not affect the homeostasis of the oral environment, which only suppresses the production of volatile sulfuric compounds.
PM-ext showed 14 and 33% inhibition at 200 and 500 μg/mL, respectively ( repetitive administration of a moderate agent could prevent the progress of periodontal disease and improve the oral condition, preventing bacterial growth. PM-ext showed significant suppression of MMP-1 release at 10 µg/mL without cytotoxicity as shown in Figure 1 . PM-ext suppressed release beyond the basal level according to the result. It is easy to imagine that there are various targets including suppression of produce and release of MMP-1 for PM-ext, apart from the inhibition of IL-1β. Determination of active principles for suppression of MMP-1 release PM-ext was subjected to solvent partition using ethyl acetate/water and butanol/water system. Each fraction was tested for suppression of MMP-1 release from HGF cells. The results are shown in Figure 2 . Among the fractions obtained, the ethyl acetate and butanol fraction showed relatively high potency at 10 µg/mL. The water soluble fraction also showed suppressive activity. Despite the high yield from PM-ext, the water soluble fraction was not characterized further due to its high polar property. The ethyl acetate soluble fraction was subjected to successive silica gel column chromatography and preparative HPLC to isolate pterostilbene (1), (+)-liquiritigenin (2) and isoliquiritigenin (3) (Figure 3 ). On the other hand, butanol soluble fraction was further purified with silica gel column chromatography and preparative HPLC to obtain coatline A (4a) and α-epi-coatline A (4b). The suppressive activities of these four compounds were investigated and the results are shown in Figure 4 . Compound 1 showed suppressive activity at 0.5 µM and was the most potent of the four compounds tested without showing cytotoxicity. However, compound 1 showed cytotoxicity at 1.0 µM and the suppressive activity of compound 1 at 1.0 µM should be due its cytotoxicity. Compounds 2 and 3 showed suppressive activities in the 10~40 and 20~40 µM ranges, respectively. Interestingly, 4a showed no suppressive activity at 10 μM, while 4b showed slight activity at the same concentration (data not shown). Further investigation of 4a was discontinued due to the low availability of the compound. The activity of 4b was tested at 40 μM and showed moderate activity. The results suggest the α-R configuration is important for activity expression. Compound 1 possesses anti-MMP-2 through modulation of the mitogen-activated protein kinases (MAPK) pathway [4] . Compound 1 also inhibited the expression of MMP-2 in a rat smooth muscle cell line (A7r5) and induced the expression of TIMP-2, a specific inhibitor of MMP-2. In addition, 1 accelerated MMP-2 protein degradation. To clarify the mechanism, 1 was treated with the cell line and MAPK and Akt/PI3K signal pathway expression was detected. As a result, 1 increased the phosphorylation of Erk1/2, but reduced the phosphorylation of JNK1/2. In addition, phosphorylation of p38 and Akt was unaffected. Expression of MMPs is regulated by activation of MAPK. Suppression of MMP-1 release, which was observed in this study, can be attributed to the activation of Erk1/2 and production In this report, we showed that anti-METase, anti-collagenase and suppression of MMP-1 release activities of PM-ext. The concentrations of enzyme assay and cell line assay is far different maybe due to the difference of potency of active principles. From these activists, PM-ext is a promising candidate anti-malodor agent. In addition, some active principles for the suppressive activity of MMP-1 release from HGF were identified. To the best of our knowledge, this is the first report on PM-ext and the active principles to show suppressive activities of MMP-1 release from HGF. Preparation of extracts: Heartwood of Asana was extracted with 5 times v/w of ethanol/water (1:1) for 2 hours with reflux. The extracted suspension was filtered through filter paper and filtrate was obtained. The extraction was repeated and the two filtrates were combined. Ethanol was evaporated and water was dried with a freeze drier to obtain 50% ethanol extract (PM-ext) at 11.6% yield.
METase assay:
The inhibitory assay against METase was performed according to a method reported previously [5] . The samples were dissolved in dimethylsulfoxide/phosphate buffer (pH=8.0) (1:19). The sample solutions (50 μL), 6.25 mM Lmethionine (160 μL) and 25 μM pyridoxal-5'-phosphate (160 μL) were mixed. To this mixture, 2.0 U/mL METase (10 μL) was added and incubated at 37°C for 10 min. Trichloroacetic acid/water (1:1) (50 μL) was added to the reaction solution and diluted 3 times with 1 M acetate buffer (pH=5.2). A mixture of 3-methyl-2-benzothiazolinone hydrazone/1 M acetate buffer (pH 5.2) (1:99) (300 μL) was added to the reaction mixture and incubated at 50°C for 30 min. After incubation in an ambient condition, absorbance of the solution at 320 nm was measured with a spectrophotometer (UV-2450PC, Shimadzu, Kyoto, Japan) and the concentration of α-ketobutyric acid was determined.
Collagenase assay: Samples were dissolved in dimethyl sulfoxide/0.1 M Tris buffer (pH=7.1). Substrate solution was prepared by dissolving 1 mg of 4-phenylazobenzyloxycarbonyl-ProLeu-Gly-Pro-D-Arg into 2 mL of 0.1 M Tris buffer (pH=7.1). The sample solution (50 μL) and substrate solution (400 μL) were mixed and incubated at 37°C for 3 min. To this mixture, 50 µL of 0.15 U/mL collagenase solution was added and incubated at 37°C for 30 min. After incubation, 25 mM citric acid solution (1 mL) was added and further reaction terminated. Ethyl acetate (5 mL) was mixed and centrifuged at 657 x g for 5 min. The ethyl acetate layer was obtained to measure absorbance at 320 nm to determine the concentration of 4-phenylazobenzyloxycarbonyl-ProLeu. Tetracycline was used as a positive control.
Suppression of MMP-1 release assay:
Human gingival fibroblasts (HGFs) were purchased from SicenCell Research Laboratories (Carlsbad, CA) in December 2011. HGFs were maintained in Dulbecco's Modified Eagle Medium (D-MEM) medium with 10% fetal bovine serum (FBS, v/v) under 5% carbon dioxide (CO 2 ) at 37°C. The cells in passage 3 to 8 were used for the assay. HGFs were seeded in a 6 well microplate and incubated at 37°C under a 5% carbon dioxide condition until the cells were confluent. Cells were washed with 1 mL of phosphate buffered saline (PBS, pH=7.4) twice. Samples and interleukin (IL)-1β was dissolved into a D-MEM medium without FBS and 2 mL of solution was added to the cell and incubated at 37°C under 5% carbon dioxide for 48 hrs. After incubation, 1 mL of the medium was withdrawn and centrifuged at 12,000 x g at 15°C for 15 min and the supernatant was obtained. The portion of supernatant was subjected to successive SDS-PAGE and western blotting using anti-MMP-1 antibody and horseradish peroxidase-linked anti-goat IgG antibody as primary and secondary antibodies, respectively. After visualizing the membrane with ECL-Plus reagent (GE Healthcare Japan, Hino, Japan), the membrane was analyzed with ChemiDOC XRS Plus System (Bio-Rad Laboratories Inc., Hercules, CA) using Quantity One 1-D Analysis Software for quantification of relative density.
Purification of active principles: PM-ext (40 g) was subjected to successive partitioning using ethyl acetate/water and butanol/water. The ethyl acetate soluble fraction (5.6 g) was subjected to silica gel column chromatography (280 g, 2.25 i.d. x 40 cm) using a mixture of hexane/ethyl acetate in gradient condition from 1:0 to 0:1 to obtain 30 fractions, which combined into 5 fractions (A~E) according to TLC analysis. Fr. B (1.08 g) was subjected to preparative HPLC under the following conditions: column; Waters 
Structural elucidation:
The chemical structures of compounds 1, 2, 3, 4a and 4b were elucidated by analyzing optical rotation and NMR spectra including 1 H (DQF-COSY, HSQC and HMBC) and 13 C (broad band decoupling, DEPT) measurements. Data were compared to a previous report to clarify the structure of compounds 1, 2, 3, 4a and 4b as pterostilbene, (+)-liquiritigenin, isoliquritigenin, coatline A and α-epi-coatline A, respectively (Figure 3 ) [6] [7] [8] [9] [10] .
Statistical analysis: All data were statistically analyzed with Statcel3 (The Publisher OMS, Tokorozawa, Japan), add-in software for Excel®, using one-way analysis of variance. Significant difference was analyzed with Dunnet's algorithm at P<0.01 or P<0.05.
